Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas–a possible mechanism for altering the nm23-H1 activity

Abstract

PRUNE, the human homologue of the Drosophila gene, is located in 1q21.3, a region highly amplified in human sarcomas, malignant tumours of mesenchymal origin. Prune protein interacts with the metastasis suppressor nm23-H1, but shows impaired affinity towards the nm23-H1 S120G mutant associated with advanced neuroblastoma. Based on these observations, we previously suggested that prune may act as a negative regulator of nm23-H1 activity. We found amplification of PRUNE in aggressive sarcoma subtypes, such as leiomyosarcomas and malignant fibrous histiocytomas (MFH) as well as in the less malignant liposarcomas. PRUNE amplification was generally accompanied by high mRNA and moderate to high protein levels. The sarcoma samples expressed nm23-H1 mostly at low or moderate levels, whereas mRNA and protein levels were moderate to high in breast carcinomas. For the more aggressive sarcoma subtypes, 9/13 patients with PRUNE amplification developed metastases. A similar situation was observed in all breast carcinomas with amplification of PRUNE. Infection of NIH3T3 cells with a PRUNE recombinant retrovirus increased cell proliferation. Possibly, amplification and overexpression of PRUNE has the same effect in the tumours. We suggest that amplification and overexpression of PRUNE could be a mechanism for inhibition of nm23-H1 activity that affect the development or progression of these tumours.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Banfi S, Borsani G, Rossi E, Bernard L, Guffanti A, Rubboli F, Marchitiello A, Giglio S, Coluccia E, Zollo M, Zuffardi O, Ballabio A . 1996 Nat. Genet. 13: 167–174

  • Berner J-M, Forus A, El Kahloun A, Meltzer PS, Fodstad Ø, Myklebost O . 1996 Genes Chromosom. Cancer 17: 245–259

  • Berner J-M, Meza-Zepeda LA, Kools PFJ, Forus A, Schoenmakers EFPM, Van de Ven WJM, Fodstad Ø, Myklebost O . 1997 Oncogene 14: 2935–2941

  • Biggs J, Hersperger E, Steeg PS, Liotta LA, Shearn A . 1990 Cell 63: 933–940

  • Biggs J, Tripoulas N, Hersperger E, Dearolf C, Shearn A . 1988 Genes Dev. 2: 1333–1343

  • Caligo MA, Cippolini G, Berti A, Viacava P, Collecchi P, Bevilaqua G . 1997 Int. J. Cancer 74: 102–111

  • Chang CL, Zhu XX, Thoraval DH, Ungar D, Rawwas J, Hora N, Strahler JR, Hanash SM, Radany E . 1994 Nature 370: 335–336

  • Cippolini G, Berti A, Fiore L, Rainaldi G, Basolo F, Merlo G, Bevilacqua G, Caligo MA . 1997 Int. J. Cancer 73: 297–302

  • de la Rosa A, Williams RL, Steeg PS . 1995 Bioessays 17: 53–62

  • Enzinger FM, Weiss SW . 1995 Soft tissue tumors, 3rd edn Mosby-Year Book Inc., St. Louis

    Google Scholar 

  • Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland ØS, Fodstad Ø . 1992 Cancer Res. 52: 6088–6091

  • Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad Ø, Myklebost O . 1993 Cell Growth Diff. 4: 1065–1070

  • Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O, Geurts van Kessel A . 1995a Genes Chromosom Cancer 14: 8–14

  • Forus A, Olde Weghuis D, Smeets D, Fodstad Ø, Myklebost O, Geurts van Kessel A . 1995b Genes Chromosom Cancer 14: 15–21

  • Forus A, Berner J-M, Meza-Zepeda LA, Fodstad Ø, Mischke D, Myklebost O . 1998 Br. J. Cancer 78: 495–503

  • Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, Saeter G, Knuutila S, Myklebost O . 2001 Cancer Genet Cytogenet. 125: 100–111

  • Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T . 1997 Cancer Res. 57: 481–487

  • Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgori D, Osborne CK, Clark G, Steeg PS . 2001 Cancer Res. 61: 2320–2327

  • He J, Olson JJ, James CD . 1995 Cancer Res. 55: 4833–4836

  • Hennessy C, Henry JA, May FE, Westley BR, Angus B, Lennard TW . 1991 J. Natl. Cancer Inst. 83: 281–285

  • Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, Kaneko M, Ohkawa H, Nakagawara A, Miwa M, Uchida K . 1999 Genes Chromosom Cancer 25: 261–269

  • Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D . 1992 Science 258: 818–821

  • Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT . 1993 Cancer Res. 53: 5535–5541

  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schrami P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi O-P . 1998 Nature Med. 4: 844–847

  • Kudoh K, Takano M, Koshikawa T, Hirai M, Yoshida S, Mano Y, Yamamoto K, Ishii K, Kita T, Kikuchi Y, Nagata I, Miwa M, Uchida K . 1999 Clin Cancer Res. 5: 2526–2531

  • Leone A, Flatow U, King CR, Sandeen MA, Margulies I, Liotta LA, Steeg PS . 1991 Cell 65: 25–35

  • Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS . 1993 Oncogene 8: 855–865

  • Lindsley DL, Zimm GG . 1992 The genome of Drosophila Melanogaster Academic Press, San Diego

    Google Scholar 

  • Lombardi D, Lacombe ML, Paggi MG . 2000 J. Cell Physiol. 182: 144–149

  • Marenholz I, Volz A, Ziegler A, Davies A, Ragoussis I, Korge BP, Mischke D . 1996 Genomics 37: 295–302

  • Martinez JA, Prevot S, Nordlinger B, Nguyen TM, Lacarriere Y, Munier A, Lascu I, Vaillant JC, Capeau J, Lacombe ML . 1995 Gut 37: 712–720

  • Momand J, Zambetti GP, Olson DC, George D, Levine AJ . 1992 Cell 69: 1237–1245

  • Muller W, Schneiders A, Hommel G, Gabbert HE . 1998 Cancer 83: 2481–2487

  • Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . 1992 Nature 358: 80–83

  • Orevi N, Falk R . 1975 Mutat. Res. 33: 193–200

  • Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 80: 8392–8396

  • Pedeutour F, Forus A, Coindre J-M, Berner J-M, Nicolo G, Michiels J-F, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C . 1999 Genes Chromosom. Cancer 24: 30–41

  • Pilotti S, Della Torre G, Lavarino C, Sozzi G, Minoletti F, Vergani B, Azzarelli A, Rilke F, Pierotti MA . 1998 J. Pathol. 185: 1881–1890

  • Qin L-X, Tang Z-Y, Sham JST, Ma Z-C, Ye S-L, Zhou X-D, Wu Z-Q, Trent JM, Guan X-Y . 1999 Cancer Res. 59: 5662–5665

  • Reymond A, Volorio S, Merla G, Al-Maghtheh M, Zuffardi O, Bulfone A, Ballabio A, Zollo M . 1999 Oncogene 18: 7244–7252

  • Royds JA, Robinson MH, Stephenson TJ, Rees RC, Fisher C . 1997 Br. J. Cancer 75: 1195–1200

  • Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB . 1993 J. Natl. Cancer Inst. 85: 727–731

  • Roymans D, Vissenberg K, De Jonghe C, Willems R, Engler G, Kimura N, Grobben B, Claes P, Verbelen JP, Van Broeckhoven C, Slegers H . 2001 Exp. Cell Res. 262: 145–153

  • Russell RL, Pedersen AN, Kantor J, Geisinger K, Long R, Zbieranski N, Townsend A, Shelton B, Brunner N, Kute TE . 1998 Br. J. Cancer 78: 710–717

  • Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A . 1994 Oncogene 9: 509–516

  • Sastre-Garau X, Lacombe ML, Jouve M, Veron M, Magdelenat H . 1992 Int. J. Cancer 50: 533–538

  • Schraml P, Kononen J, Bubendorf L, Mocj H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi O-P, Sauter G . 1999 Clin. Cancer Res. 5: 1966–1975

  • Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van den Berg E, Myklebost O, Bridge J, Geurts van Kessel A, Suijkerbuijk R . 2000 Cancer Genet. Cytogenet. 118: 89–98

  • Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC . 1996 Gynecol. Oncol. 60: 363–372

  • Subramanian C, Cotter MA II, Robertson ES . 2001 Nature Med. 7: 350–355

  • Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomquist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S . 1996 Genes Chromosom. Cancer 15: 89–94

  • Tapper J, Sarantaus L, Vahteristo P, Nevanlinna H, Hemmer S, Seppala M, Knuutila S, Butzow R . 1998 Cancer Res. 58: 2715–2719

  • Tarkkanen M, Elomaa I, Blomqvist C, Kivioja AH, Kellokumpu-Lehtinen P, Bohling T, Valle J, Knuutila S . 1999 Int. J. Cancer 84: 114–121

  • Timmons L, Shearn A . 1996 Genetics 144: 1589–1600

  • Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi O-P . 1998 Genes Chromosom. Cancer 21: 177–184

  • Tseng YH, Vicent D, Zhu J, Niu Y, Adeyinka A, Moyers JS, Watson PH, Kahn CR . 2001 Cancer Res. 61: 2071–2079

  • Volorio S, Simon G, Repetto M, Cucciardi M, Banfi S, Borsani G, Ballabio A, Zollo M . 1998 DNA Seq. 9: 307–315

  • Weiss SW . 1994 Histological Typing of Soft Tissue Tumours Springer-Verlag, Berlin

    Book  Google Scholar 

  • White PS, Forus A, Matise TC, Schutte BC, Spicker N, Stahier P, Vance JM, Gregory SG . 1999 Cytogenet. Cell Genet. 87: 143–171

  • Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ . 1999 Am. J. Pathol. 154: 37–43

  • Zimonjic DB, Keck CL, Thorgeirsson SS, Popescu NC . 1999 Hepatology 29: 1208–1214

Download references

Acknowledgements

We thank Dr Felice Tirone for providing pBABE puro vector and BOSC23 cell lines, Dr Massimo Santoro for providing RET/PTC3 clone and Dr Caterina Missero for critical review of the manuscript. The work was supported by grants from the Norwegian Cancer Society, the Norwegian Research Council, Telethon grant TIGEM 96-2001, Regione Campania grant 2001 to M Zollo, Ligue Suisse contre le cancer grant to A Reymond, and by the Italian Cancer foundation AIRC-FIRC fellowships sponsored to A D'Angelo, F Blanco and G Merla.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Zollo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forus, A., D'Angelo, A., Henriksen, J. et al. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas–a possible mechanism for altering the nm23-H1 activity. Oncogene 20, 6881–6890 (2001). https://doi.org/10.1038/sj.onc.1204874

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204874

Keywords

This article is cited by

Search

Quick links